Medical advances can’t happen without teamwork. Each new discovery, treatment or cure is the culmination of research from both the public and private sectors, spanning federal agencies, businesses, universities and other key institutions. Without the participation of each member of the team, innovation can’t thrive. Private sector investment has impact: the life sciences industry researches and develops lifesaving pharmaceuticals, innovative diagnostic methods, critical prevention measures and more. These discoveries are interwoven into the fabric of everyday lives, so it’s easy to take them for granted. But that would be a mistake. When it comes to empowering people to live longer and in better health, good isn’t good enough. Our nation is the top medical innovator in the world, and that’s something to celebrate. We need Washington to create a policy environment in which our nation’s life sciences pipeline – fueled by public sector and private sector investment – can continue to fight back against deadly and disabling diseases. We need champions in Congress and in the White House who will stand up and fight for federal funding and private sector incentives, because every piece of the R&D puzzle is essential to faster progress.